CoChat

A mutation in the major autophagy gene, WIPI2, associated with global developmental abnormalities

Open access

The DOI matches its Crossref record; 52 of the 53 references it cites were found in a registry or an index.

Abstract

We describe a large consanguineous pedigree from a remote area of Northern Pakistan, with a complex developmental disorder associated with wide-ranging symptoms, including mental retardation, speech and language impairment and other neurological, psychiatric, skeletal and cardiac abnormalities. We initially carried out a genetic study using the HumanCytoSNP-12 v2.1 Illumina gene chip on nine family members and identified a single region of homozygosity shared amongst four affected individuals on chromosome 7p22 (positions 3059377-5478971). We performed whole-exome sequencing on two affected individuals from two separate branches of the extended pedigree and identified a novel nonsynonymous homozygous mutation in exon 9 of the WIPI2 (WD-repeat protein interacting with phosphoinositide 2) gene at position 5265458 (c.G745A;pV249M). WIPI2 plays a critical role in autophagy, an evolutionary conserved cellular pathway implicated in a growing number of medical conditions. The mutation is situated in a highly conserved and critically important region of WIPI2, responsible for binding PI(3)P and PI(3,5)P2, an essential requirement for autophagy to proceed. The mutation is absent in all public databases, is predicted to be damaging and segregates with the disease phenotype. We performed functional studies in vitro to determine the potential effects of the mutation on downstream pathways leading to autophagosome assembly. Binding of the V231M mutant of WIPI2b to ATG16L1 (as well as ATG5-12) is significantly reduced in GFP pull-down experiments, and fibroblasts derived from the patients show reduced WIPI2 puncta, reduced LC3 lipidation and reduced autophagic flux.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1093/brain/awz075

Cites

52 of 52 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 Large consanguineous pedigree from Northern Pakistan. Affected members of the family present with a complex developmental disorder affecting multiple tissues segregating as an autosomal recessive condition. Two affected individuals (Patients NA and AA) from two separate branches of the family were selected for exome sequencing. Cells derived from an unaffected healthy sibling (Subject RG) and an affected individual (Patient AA) were used in the functional studies. Individuals NA, RG and AA are indicated with arrows. The cG745A mutation reported in this family was confirmed by Sanger sequencing (Fig. 3) in 10 family members marked with an asterisk. Their corresponding genotypes (G/G, G/A, A/A) are given.
Figure 1 Large consanguineous pedigree from Northern Pakistan. Affected members of the family present with a complex developmental disorder affecting multiple tissues segregating as an autosomal recessive condition. Two affected individuals (Patients NA and AA) from two separate branches of the family were selected for exome sequencing. Cells derived from an unaffected healthy sibling (Subject RG) and an affected individual (Patient AA) were used in the functional studies. Individuals NA, RG and AA are indicated with arrows. The cG745A mutation reported in this family was confirmed by Sanger sequencing (Fig. 3) in 10 family members marked with an asterisk. Their corresponding genotypes (G/G, G/A, A/A) are given.CC BY · PubMed Central
Figure 2 Skeletal and neurological abnormalities in patients. (A–C) Patient AA, aged 43 years, and Patient NA (D–I), aged 45 years, show a range of clinical abnormalities, including clinodactyly, overlapping of fifth toes, increased thoracic kyphosis, thumb hypoplasia and enlarged ventricles in the brain.
Figure 2 Skeletal and neurological abnormalities in patients. (A–C) Patient AA, aged 43 years, and Patient NA (D–I), aged 45 years, show a range of clinical abnormalities, including clinodactyly, overlapping of fifth toes, increased thoracic kyphosis, thumb hypoplasia and enlarged ventricles in the brain.CC BY · PubMed Central
Figure 3 Genomic structure and mutation in WIPI2 gene. (A) The exon-intron structure of the WIPI2 gene is depicted, highlighting the pV249M mutation. (B) Phylogenetic analysis demonstrates the cG745A mutation is in a region that is highly conserved across multiple species. (C) Model of WIPI2 (Wilson et al., 2014) based on the structure of Hsv2 (Baskaran et al., 2012). WIPI2 is a 7-bladed propeller protein capable of interacting with PI(3)P and PI(3,5)P2 at sites 1 and 2. The WIPI2 pV249M mutation resides within site 2 in blade 6. (D) Sanger sequencing confirms the cG745A mutation correctly segregates with the phenotype in 10 family members (Fig. 1). Representative sequence traces from affected (−/−), unaffected (+/−) and control (+/+) individuals are presented, corresponding to genotypes AA, AG and GG, respectively. (E) Sequence alignment of PROPPIN family members. The boxed region highlights the position of the pV249M residue and its comparison across PROPPIN family members. Figure adapted from Baskaran et al. (2012). Residues involved in binding PI(3)P and PI(3,5)P2, including R243, which is an essential requirement for binding to occur, are highlighted in yellow.
Figure 3 Genomic structure and mutation in WIPI2 gene. (A) The exon-intron structure of the WIPI2 gene is depicted, highlighting the pV249M mutation. (B) Phylogenetic analysis demonstrates the cG745A mutation is in a region that is highly conserved across multiple species. (C) Model of WIPI2 (Wilson et al., 2014) based on the structure of Hsv2 (Baskaran et al., 2012). WIPI2 is a 7-bladed propeller protein capable of interacting with PI(3)P and PI(3,5)P2 at sites 1 and 2. The WIPI2 pV249M mutation resides within site 2 in blade 6. (D) Sanger sequencing confirms the cG745A mutation correctly segregates with the phenotype in 10 family members (Fig. 1). Representative sequence traces from affected (−/−), unaffected (+/−) and control (+/+) individuals are presented, corresponding to genotypes AA, AG and GG, respectively. (E) Sequence alignment of PROPPIN family members. The boxed region highlights the position of the pV249M residue and its comparison across PROPPIN family members. Figure adapted from Baskaran et al. (2012). Residues involved in binding PI(3)P and PI(3,5)P2, including R243, which is an essential requirement for binding to occur, are highlighted in yellow.CC BY · PubMed Central
Figure 4 WIPI2 puncta formation is inhibited in human fibroblasts isolated from patients carrying a WIPI2 mutation. (A) Control (RG) and mutant (AA) human fibroblasts were incubated in either full medium (FM), or treated with 100 nM Bafilomycin A1 in full-nutrient medium (FB), or amino acid starvation medium (SM), or 100 nM Bafilomycin A1 in starvation medium (SB) for 2 h and then fixed. Cells were stained with antibodies against WIPI2 and LC3. Scale bar = 10 μm. (B and C) WIPI2 and LC3 puncta were quantified in 10 fields per condition. Statistical analysis was performed by one-way ANOVA with Tukey’s post-test. ****P < 0.0001.
Figure 4 WIPI2 puncta formation is inhibited in human fibroblasts isolated from patients carrying a WIPI2 mutation. (A) Control (RG) and mutant (AA) human fibroblasts were incubated in either full medium (FM), or treated with 100 nM Bafilomycin A1 in full-nutrient medium (FB), or amino acid starvation medium (SM), or 100 nM Bafilomycin A1 in starvation medium (SB) for 2 h and then fixed. Cells were stained with antibodies against WIPI2 and LC3. Scale bar = 10 μm. (B and C) WIPI2 and LC3 puncta were quantified in 10 fields per condition. Statistical analysis was performed by one-way ANOVA with Tukey’s post-test. ****P < 0.0001.CC BY · PubMed Central
Figure 5 Analysis of WIPI2 interaction with ATG16L1. (A) GFP-WIPI2b WT or GFP-WIPI2b V231M were transiently expressed in HEK293A cells. The cells were lysed and subjected to immunoprecipitation using GFP-TRAP beads. ATG16L1, ATG12 and GFP (alone or GFP-WIPI2b), in the input, unbound and bound to the GFP-TRAP beads, were detected using the specific antibodies against ATG16L1, ATG12 and GFP. Note data are from same western blot but shown in pieces to aid interpretation. (B) Total cell lysate from the unaffected control (RG) and the patient (AA) were analysed for levels of FIP200, ATG16L1 and WIPI2. (C) Cell lysates from the control (RG) or the patient (AA) were prepared after the treatment of the respective cell lines with a crosslinker on ice. WIPI2 was immunoprecipitated with an antibody against WIPI2, and the input, unbound and immunoprecipitates were analysed by western blot, using antibodies against ATG16L1 and WIPI2. The WIPI2 immunoprecipitation was done with antibody plus protein A beads (beads + Ab) or antibody alone (Ab).
Figure 5 Analysis of WIPI2 interaction with ATG16L1. (A) GFP-WIPI2b WT or GFP-WIPI2b V231M were transiently expressed in HEK293A cells. The cells were lysed and subjected to immunoprecipitation using GFP-TRAP beads. ATG16L1, ATG12 and GFP (alone or GFP-WIPI2b), in the input, unbound and bound to the GFP-TRAP beads, were detected using the specific antibodies against ATG16L1, ATG12 and GFP. Note data are from same western blot but shown in pieces to aid interpretation. (B) Total cell lysate from the unaffected control (RG) and the patient (AA) were analysed for levels of FIP200, ATG16L1 and WIPI2. (C) Cell lysates from the control (RG) or the patient (AA) were prepared after the treatment of the respective cell lines with a crosslinker on ice. WIPI2 was immunoprecipitated with an antibody against WIPI2, and the input, unbound and immunoprecipitates were analysed by western blot, using antibodies against ATG16L1 and WIPI2. The WIPI2 immunoprecipitation was done with antibody plus protein A beads (beads + Ab) or antibody alone (Ab).CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 52 references

Cited by

Metadata

Authors
Jelani, M., Dooley, H. C., Gubas, A., Mohamoud, H. S. A., Khan, M. T. M., Ali, Z., Kang, C., Rahim, F., Jan, A., Vadgama, N., Khan, M. I., Al-Aama, J. Y., Khan, A., Tooze, S. A., & Nasir, J.
Affiliations
  • King Abdulaziz University (SA)
  • The Francis Crick Institute (GB)
  • The Francis Crick Institute, Molecular Cell Biology of Autophagy, London, UK
  • St George’s University Hospitals NHS Foundation Trust (GB)
  • Islamia College University (PK)
  • King Abdullah University of Science and Technology (SA)
  • Sungshin Women's University (KR)
  • Bacha Khan Medical College (PK)
  • Northwest School of Medicine (PK)
  • St George's, University of London (GB)
  • Abdul Wali Khan University Mardan (PK)
Corresponding author
Nasir, Jamal
Venue
Brain
Published
2019-04-10
Volume
142
Issue
5
Pages
1242-1254
ISSN
  • 0006-8950 (ISSN-L)
  • 1460-2156
OpenAlex
W2939331244
Cited by
48
References
53
Citations by year
2026: 7 · 2025: 5 · 2024: 5 · 2023: 6 · 2022: 6 · 2021: 10 · 2020: 5 · 2019: 3
FWCI
4.57
Type
journal article
Language
en
Open access
Locations
  • Brain (publishedVersion, cc-by)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • NECTAR - Northampton Electronic Collection of Thesis and Research (University of Northampton) (submittedVersion)
  • Figshare (submittedVersion, cc-by)
  • King Abdullah University of Science and Technology Repository (King Abdullah University of Science and Technology) (submittedVersion, other-oa)
  • The Francis Crick Institute (cc-by)
  • Greater South Information System
Funders
  • Francis Crick Institute
  • Cancer Research UK (FC001187)
  • UK Medical Research Council (FC001187)
  • Wellcome Trust (FC001187)
  • Leverhulme Trade Charities Trust
  • Princess Al-Jawhara Albrahim Centre of Excellence in Research of Hereditary Disorders
  • King Abdulaziz University
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Autophagy in Disease and Therapy
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genomics and Rare Diseases
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetics and Neurodevelopmental Disorders
Keywords
WIPI2, autophagy, consanguinity, homozygosity mapping, non-synonymous mutations, developmental disorders, intellectual disability, ATG16L1, LC3 lipidation, autophagic flux, fibroblasts
MeSH terms
Adult, Amino Acid Sequence, Autophagy, Cells, Cultured, Developmental Disabilities, Female, Humans, Male, Membrane Proteins, Middle Aged, Mutation, Pedigree, Protein Structure, Secondary, Phosphate-Binding Proteins, HEK293 Cells

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.